According to Novo Nordisk latest financial reports the total debt is $2.85B, an decrease of -15.59% to 2022. At the end of 2022 company had $3.37B total debt. This figure represents the debts and financial obligations that Novo Nordisk combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $2.85B | -15.59% |
2022 | $3.37B | 87.62% |
2021 | $1.80B | 347.39% |
2020 | $401.86M | -3.72% |
2019 | $417.40M | - |